Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News ESC 2016

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

Todd Neale

August 28, 2016

News Daily News

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

L.A. McKeown

August 17, 2016

News Daily News

Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI

L.A. McKeown

August 17, 2016

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Yael L. Maxwell

December 22, 2015

News Daily News

Un Estudio Avala el Uso de Dosis Bajas de Aspirina Post-IAM

Todd Neale

May 28, 2015

News Daily News

Study Supports Use of Low-Dose Aspirin After Acute MI

Todd Neale

May 28, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

May 14, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

就在接受PCI前的阿司匹林高反应性导致结果更差

September 02, 2014

News Daily News

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

September 02, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

Advertisement

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Un Estudio Avala el Uso de Dosis Bajas de Aspirina Post-IAM

Study Supports Use of Low-Dose Aspirin After Acute MI

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

就在接受PCI前的阿司匹林高反应性导致结果更差

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content